MedPath

Randomized Double-blind Controlled Study of Shenshi Shengdiqinlian Tufuling Decoction in the Treatment of Mucocutaneous Behcet's Disease

Phase 1
Not yet recruiting
Conditions
Behcet's Disease
Registration Number
ITMCTR2000003766
Lead Sponsor
Shanghai Traditional Chinese Medicine Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

1. Aged >= 16 years;
2. In compliance with the 2013 International Behets disease diagnostic criteria;
3. The patient or his family members signed the informed consent.

Exclusion Criteria

Exclude other autoimmune diseases (systemic lupus erythematosus, Crohns disease, ulcerative colitis), exclude infection-related diseases (syphilis, active Tuberculosis), exclude the tumor.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.